Pfizer Announces New Occupants in its Science Incubator

Wintherix LLC Searches for Cancer Therapies Acting Through a Novel Pathway

RGo Bioscience LLC Seeks New Ways to Deliver and Dose Next-Generation Medicines

Pfizer today announced two new occupants for the company’s Incubator – a new development where scientific entrepreneurs progress their ideas towards innovative treatments for serious diseases.

Wintherix LLC was founded by a team led by Dr. Dennis Carson, Director of the Moores Cancer Center and Professor of Medicine at UCSD School of Medicine. The new company will use its proprietary biological knowledge and Pfizer’s compound library to search for molecules that inhibit wnt-related signaling pathways in cancer cells. Wnt-signaling is thought to play a role in the development of cancer in humans and represents a potential new way to treat the disease.

RGo Bioscience LLC was co-founded by Dr. Alexander Chucholowski, previously President of ChemBridge Research Laboratories (CRL), and Dr. Thomas Hermann, an Assistant Professor at the University of California, San Diego (UCSD), where he researches the potential of small molecules to act on ribonucleic acid (RNA). RNA plays a key role in many disease mechanisms and the new company aims to develop novel ways to deliver RNAs into the human body.

In July 2007, Pfizer announced the first occupant of its Incubator - Vaughn Smider MD, PhD, an assistant professor at The Scripps Research Institute in La Jolla, CA. Dr. Smider and his company, Fabrus LLC, are working to develop novel antibody libraries and ways to screen the libraries against biological targets. The technology will be tested on targets relevant to some of Pfizer’s 11 therapeutic areas.

About The Pfizer Incubator

The Pfizer Incubator (TPI) offers scientist-entrepreneurs an opportunity to bring their medical innovations to patients. In TPI, scientist-entrepreneurs contribute innovative ideas and the ability to solve complex scientific and technical challenges, while TPI provides all necessary resources to move ideas forward into practice.

More details are at: www.thepfizerincubator.com

Contact

Shreya Jani

212-733-4889